Sep 10 2009
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in the 3rd annual World Drug Safety Congress Europe, to be held September 15-18 at the Bloomsbury Hotel in London, U.K.
On Wednesday, September 16, from 1:30-2:00 p.m. local time, Robert Weber, principal consultant of Phase Forward’s Lincoln Safety Group, will participate in stream session 2 titled “Post Marketing Safety Strategy.” Mr. Weber’s presentation will review the prioritization, tracking and management of signals from multiple sources, such as spontaneous adverse event reports, clinical studies and observational studies. In addition, Mr. Weber will discuss the importance of processes and integrated tools to deliver improved safety monitoring and risk management.
Phase Forward will also showcase its safety solutions, the Empirica™ Suite, which comprises the following products: Empirica Trace, Empirica Gateway, Empirica Signal and Empirica Study.
http://www.phaseforward.com/